HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 108 filers reported holding HERON THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $645,645 | +66.2% | 184,472 | +31.5% | 0.00% | – |
Q1 2024 | $388,454 | +68.3% | 140,242 | +3.3% | 0.00% | – |
Q4 2023 | $230,845 | +65.8% | 135,797 | +0.4% | 0.00% | – |
Q3 2023 | $139,243 | -12.6% | 135,202 | -1.6% | 0.00% | – |
Q2 2023 | $159,404 | +77280.6% | 137,418 | +0.7% | 0.00% | – |
Q1 2023 | $206 | -38.0% | 136,445 | +2.7% | 0.00% | – |
Q4 2022 | $332 | -99.9% | 132,887 | +2.8% | 0.00% | -100.0% |
Q3 2022 | $545,000 | +61.7% | 129,259 | +7.0% | 0.00% | – |
Q2 2022 | $337,000 | -41.8% | 120,787 | +19.3% | 0.00% | -100.0% |
Q1 2022 | $579,000 | -38.5% | 101,284 | -1.8% | 0.00% | 0.0% |
Q4 2021 | $941,000 | -16.2% | 103,098 | -1.8% | 0.00% | -50.0% |
Q3 2021 | $1,123,000 | -28.2% | 105,039 | +4.2% | 0.00% | 0.0% |
Q2 2021 | $1,565,000 | -7.9% | 100,829 | -3.9% | 0.00% | 0.0% |
Q1 2021 | $1,700,000 | -30.2% | 104,876 | -8.8% | 0.00% | -33.3% |
Q4 2020 | $2,435,000 | +43.1% | 115,038 | +0.2% | 0.00% | 0.0% |
Q3 2020 | $1,702,000 | -14.2% | 114,862 | -14.8% | 0.00% | 0.0% |
Q2 2020 | $1,983,000 | +43.5% | 134,826 | +14.5% | 0.00% | 0.0% |
Q1 2020 | $1,382,000 | -48.1% | 117,716 | +4.0% | 0.00% | -25.0% |
Q4 2019 | $2,661,000 | +42.7% | 113,227 | +12.3% | 0.00% | +33.3% |
Q3 2019 | $1,865,000 | +0.6% | 100,802 | +1.1% | 0.00% | 0.0% |
Q2 2019 | $1,853,000 | -14.4% | 99,678 | +12.5% | 0.00% | -25.0% |
Q1 2019 | $2,165,000 | -6.8% | 88,585 | -1.1% | 0.00% | -20.0% |
Q4 2018 | $2,323,000 | +24.8% | 89,541 | +52.2% | 0.01% | +25.0% |
Q3 2018 | $1,862,000 | -19.3% | 58,829 | -1.0% | 0.00% | -20.0% |
Q2 2018 | $2,308,000 | +69.8% | 59,401 | +20.7% | 0.01% | +66.7% |
Q1 2018 | $1,359,000 | +74.9% | 49,228 | +14.7% | 0.00% | +50.0% |
Q4 2017 | $777,000 | -5.9% | 42,906 | -16.1% | 0.00% | 0.0% |
Q3 2017 | $826,000 | +17.8% | 51,120 | +1.0% | 0.00% | 0.0% |
Q2 2017 | $701,000 | +5.3% | 50,630 | +14.1% | 0.00% | 0.0% |
Q1 2017 | $666,000 | +47.0% | 44,381 | +28.3% | 0.00% | +100.0% |
Q4 2016 | $453,000 | -25.9% | 34,603 | -2.4% | 0.00% | -50.0% |
Q3 2016 | $611,000 | -3.8% | 35,466 | +0.8% | 0.00% | 0.0% |
Q2 2016 | $635,000 | +14.8% | 35,201 | +20.8% | 0.00% | 0.0% |
Q1 2016 | $553,000 | -28.7% | 29,134 | +0.3% | 0.00% | 0.0% |
Q4 2015 | $776,000 | +20.9% | 29,054 | +10.4% | 0.00% | 0.0% |
Q3 2015 | $642,000 | -4.6% | 26,319 | +21.9% | 0.00% | 0.0% |
Q2 2015 | $673,000 | +116.4% | 21,585 | +1.1% | 0.00% | +100.0% |
Q1 2015 | $311,000 | +88.5% | 21,350 | +29.8% | 0.00% | – |
Q4 2014 | $165,000 | +25.0% | 16,450 | +3.6% | 0.00% | – |
Q3 2014 | $132,000 | -23.3% | 15,875 | +13.8% | 0.00% | -100.0% |
Q2 2014 | $172,000 | – | 13,950 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |